Conference Proceedings

Trial in progress: A phase III, randomized, open-label study comparing zanubrutinib plus rituximab versus bendamustine plus rituximab in patients with previously untreated mantle cell lymphoma (MCL).

martin H Dreyling, Constantine Si Lun Tam, Michael Wang, Stephen Douglas Smith, Marco Ladetto, Huiqiang Huang, Rebecca L Elstrom, Melannie Co, Eric Holmgren, Jane Huang, Steven Le Gouill

JOURNAL OF CLINICAL ONCOLOGY | LIPPINCOTT WILLIAMS & WILKINS | Published : 2020

Grants

Funding Acknowledgements

BeiGene